Recruitment of C-terminal Src kinase by the leukocyte inhibitory receptor CD85j

被引:39
作者
Sayós, J
Martínez-Barriocanal, A
Kitzig, F
Bellón, T
López-Botet, M
机构
[1] Univ Pompeu Fabra, DCEXS, Mol Immunopathol Unit, Barcelona, Spain
[2] Hosp Univ La Paz, Serv Alergia, Madrid, Spain
关键词
inhibitory receptors; CD85j; Csk; SHP-1; Src kinases;
D O I
10.1016/j.bbrc.2004.09.097
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The CD85j inhibitory receptor (also termed ILT2 or LIR-1) is a type-I transmembrane protein that belongs to the Ig superfamily and is expressed by different leukocyte lineages. The extracellular region of CD85j binds HLA class I molecules and its cytoplasmic domain displays four immunoreceptor tyrosine-based inhibition motifs (ITIM). Upon tyrosine phosphorylation CD85j recruits the SHP-1 tyrosine phosphatase, involved in negative signaling. In order to identify other molecules to which CD85j might interact with in a phosphotyrosine-dependent manner, a cDNA B-cell library was screened in a three-hybrid system in yeast using the CD85j cytoplasmic tail as bait in the presence of the Src-kinase c-fyn(420), (531Y-F). (176R-Q) mutant. In this system, the C-terminal Src kinase (Csk) was shown to interact with CD85j. Phosphorylation-dependent recruitment of Csk to the CD85j cytoplasmic tail was confirmed in CD85j-transfected mammalian cells by immunoprecipitation and Western blot analysis. Mutational analyses and phospho-peptide mapping suggested that the SH2 domain of Csk may preferentially bind to ITIM Y562 of CD85j; yet, mutation to phenylalanine of Y533, Y614, and Y644 also significantly reduced Csk recruitment by CD85j. Even though CD85j was detected in both anti-SHP1 and CSK immunoprecipitates, these two molecules did not co-precipitate together with CD85j. Our data support the possibility that Csk regulates the function of CD85j. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:640 / 647
页数:8
相关论文
共 32 条
[1]
The ILT family of leukocyte receptors [J].
Allan, DSJ ;
McMichael, AJ ;
Braud, VM .
IMMUNOBIOLOGY, 2000, 202 (01) :34-41
[2]
Mutational analysis of immunoreceptor tyrosine-based inhibition motifs of the Ig-like transcript 2 (CD85j) leukocyte receptor [J].
Bellón, T ;
Kitzig, F ;
Sayós, J ;
López-Botet, M .
JOURNAL OF IMMUNOLOGY, 2002, 168 (07) :3351-3359
[3]
Borges L, 1997, J IMMUNOL, V159, P5192
[4]
Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase Csk and is involved in regulation of T cell activation [J].
Brdicka, T ;
Pavilstová, D ;
Leo, A ;
Bruyns, E ;
Korínek, V ;
Angelisová, P ;
Scherer, J ;
Shevchenko, A ;
Shevchenko, A ;
Hilgert, I ;
Cerny, J ;
Drbal, K ;
Kuramitsu, Y ;
Kornacker, B ;
Horejsí, V ;
Schraven, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (09) :1591-1604
[5]
The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18 [J].
Chapman, TL ;
Heikema, AP ;
Bjorkman, PJ .
IMMUNITY, 1999, 11 (05) :603-613
[6]
A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells [J].
Colonna, M ;
Nakajima, H ;
Navarro, F ;
López-Botet, M .
JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 66 (03) :375-381
[7]
A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells [J].
Colonna, M ;
Navarro, F ;
Bellon, T ;
Llano, M ;
Garcia, P ;
Samaridis, J ;
Angman, L ;
Cella, M ;
LopezBotet, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (11) :1809-1818
[8]
A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules [J].
Cosman, D ;
Fanger, N ;
Borges, L ;
Kubin, M ;
Chin, W ;
Peterson, L ;
Hsu, ML .
IMMUNITY, 1997, 7 (02) :273-282
[9]
Phosphorylation-dependent regulation of T-cell activation by PAG/Cbp, a lipid raft-associated transmembrane adaptor [J].
Davidson, D ;
Bakinowski, M ;
Thomas, ML ;
Horejsi, V ;
Veillette, A .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (06) :2017-2028
[10]
Ig-like transcript 2 (ILT2)/leukocyte Ig-like receptor 1 (LIR1) inhibits TCR signaling and actin cytoskeleton reorganization [J].
Dietrich, J ;
Cella, M ;
Colonna, M .
JOURNAL OF IMMUNOLOGY, 2001, 166 (04) :2514-2521